COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
04 2022
Historique:
received: 31 10 2021
accepted: 27 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 23 4 2022
Statut: ppublish

Résumé

Currently, COVID-19 dominates the public health agenda and poses a permanent threat, leading to health systems' exhaustion and unprecedented service disruption. Primary healthcare services, including tuberculosis services, are at increased risk of facing severe disruptions, particularly in low-income and middle-income countries. Indeed, corroborating model-based forecasts, there is increasing evidence of the COVID-19 pandemic's negative impact on tuberculosis case detection. Applying a segmented time-series analysis, we assessed the effects of COVID-19-related measures on tuberculosis diagnosis service across districts in Mozambique. Ministry health information system data were used from the first quarter of 2017 to the end of 2020. The model, performed under the Bayesian premises, was estimated as a negative binomial with random effects for districts and provinces. A total of 154 districts were followed for 16 consecutive quarters. Together, these districts reported 96 182 cases of all forms of tuberculosis in 2020. At baseline (first quarter of 2017), Mozambique had an estimated incidence rate of 283 (95% CI 200 to 406) tuberculosis cases per 100 000 people and this increased at a 5% annual rate through the end of 2019. We estimated that 17 147 new tuberculosis cases were potentially missed 9 months after COVID-19 onset, resulting in a 15.1% (95% CI 5.9 to 24.0) relative loss in 2020. The greatest impact was observed in the southern region at 40.0% (95% CI 30.1 to 49.0) and among men at 15% (95% CI 4.0 to 25.0). The incidence of pulmonary tuberculosis increased at an average rate of 6.6% annually; however, an abrupt drop (15%) was also observed immediately after COVID-19 onset in March 2020. The most significant impact of the state of emergency was observed between April and June 2020, the quarter after COVID-19 onset. Encouragingly, by the end of 2020, clear signs of health system recovery were visible despite the initial shock.

Identifiants

pubmed: 35443938
pii: bmjgh-2021-007878
doi: 10.1136/bmjgh-2021-007878
pmc: PMC9021460
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
Curr Med Res Pract. 2020 Mar-Apr;10(2):78-79
pubmed: 32292804
Ann Intern Med. 2020 Aug 18;173(4):317-320
pubmed: 32251513
Eur Respir J. 2020 Oct 1;56(4):
pubmed: 32703780
Emerg Infect Dis. 2021 Jul;27(7):1831-1839
pubmed: 34152962
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
EClinicalMedicine. 2020 Oct 24;28:100603
pubmed: 33134905
Lancet Glob Health. 2020 Oct;8(10):e1273-e1281
pubmed: 32791117
WHO South East Asia J Public Health. 2020 Sep;9(2):95-99
pubmed: 32978339
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141
pubmed: 32673577
Indian J Tuberc. 2020 Dec;67(4S):S139-S146
pubmed: 33308660
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32513784
Int J Epidemiol. 2021 Jul 9;50(3):1011-1015
pubmed: 33097937
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499422
Emerg Infect Dis. 2004 Sep;10(9):1523-8
pubmed: 15498151
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1439-1443
pubmed: 32755848
Lancet Respir Med. 2020 Sep;8(9):844-846
pubmed: 32758439
Lancet Respir Med. 2021 Apr;9(4):340-342
pubmed: 33493446
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028701
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
Int J Tuberc Lung Dis. 2020 May 1;24(5):542-544
pubmed: 32398211
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21
pubmed: 32446305
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Lancet Reg Health West Pac. 2020 Oct;3:100032
pubmed: 34173601
Lancet HIV. 2020 May;7(5):e319-e320
pubmed: 32277870
Health Policy Plan. 2016 Feb;31(1):129-35
pubmed: 25887561
Trop Med Infect Dis. 2021 May 19;6(2):
pubmed: 34069332
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089
Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9
pubmed: 22323300
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):81-83
pubmed: 33384053

Auteurs

Ivan Manhiça (I)

Ministerio da Saude, Maputo, Mozambique.

Orvalho Augusto (O)

Saude da Comunidade, Faculdade de Medicina, Cidade de Maputo, Mozambique.
Department of Global Health, University of Washington, Seattle, Washington, USA.

Kenneth Sherr (K)

Department of Global Health, University of Washington, Seattle, Washington, USA.

James Cowan (J)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Rosa Marlene Cuco (RM)

Ministerio da Saude, Maputo, Mozambique.

Sãozinha Agostinho (S)

Ministerio da Saude, Maputo, Mozambique.

Bachir C Macuacua (BC)

Ministerio da Saude, Maputo, Mozambique.

Isaías Ramiro (I)

Comité para a Saúde de Moçambique, Maputo City, Mozambique.

Naziat Carimo (N)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Maria Benigna Matsinhe (MB)

Ministerio da Saude, Maputo, Mozambique.

Stephen Gloyd (S)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Sergio Chicumbe (S)

Instituto Nacional de Saude, Maputo, Mozambique.

Raimundo Machava (R)

Ministerio da Saude, Maputo, Mozambique.

Stélio Tembe (S)

Ministerio da Saude, Maputo, Mozambique.
Department of Global Health, University of Washington, Seattle, Washington, USA.

Quinhas Fernandes (Q)

Ministerio da Saude, Maputo, Mozambique ferq09@gmail.com.
Department of Global Health, University of Washington, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH